Clinical trial reportThe Lancet. OncologyPublished
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 study
15 of 45 authors shown in byline order.
Regional connection
Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Penn Medicine, Penn Presbyterian Medical Center, University of Pennsylvania, with Temple Health linked by the institution reference. Affiliation source
Publication record
- Type
- Clinical trial report
- Venue
- The Lancet. Oncology
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Carcinoma, Renal Cell; Kidney Neoplasms; Neoplasm Staging; Chemotherapy, Adjuvant; Nephrectomy; Aged; Middle Aged; Canada; Female; Male; Antineoplastic Agents, Immunological
- PubMed ID
- 38942046
- PubMed Central ID
- PMC11323681
- Open access
- Yes, accepted manuscript
- Added to directory
- Source checked